T-cell lymphoma classification: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
==Overview==
==Overview==


There is no established system for the classification of [disease name].
Tcell lymphoma may be classified according to The 2016 WHO update on mature T- and natural killer (NK) cell neoplasms.
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].


OR
OR
Line 34: Line 30:
==Classification==
==Classification==


Based on the 2017 revision of the World Health Organization classification of lymphoid neoplasms classified there are four clinical variants of adult T cell leukemia-lymphoma (ATL).<ref name="Matutes2018">{{cite journal|last1=Matutes|first1=E.|title=The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms|journal=International Journal of Laboratory Hematology|volume=40|year=2018|pages=97–103|issn=17515521|doi=10.1111/ijlh.12817}}</ref>
According to the the 2017 revision of the World Health Organization classification of lymphoid neoplasms classified there are four clinical variants of adult T cell leukemia-lymphoma (ATL).<ref name="Matutes2018">{{cite journal|last1=Matutes|first1=E.|title=The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms|journal=International Journal of Laboratory Hematology|volume=40|year=2018|pages=97–103|issn=17515521|doi=10.1111/ijlh.12817}}</ref>
*T cell prolymphocytic leukemia
*T cell prolymphocytic leukemia
*T cell large granular lymphocytic leukemia
*T cell large granular lymphocytic leukemia
Line 57: Line 53:
*Anaplastic large cell lymphoma, ALK+
*Anaplastic large cell lymphoma, ALK+
*Anaplastic large cell lymphoma, ALK–
*Anaplastic large cell lymphoma, ALK–
'''If the staging system involves specific and characteristic findings and features:'''
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
===Updated World Health Organization Classification <ref>{{cite book | last = Swerdlow | first = Steven | title = WHO classification of tumours of haematopoietic and lymphoid tissues | publisher = International Agency for Research on Cancer | location = Lyon, France | year = 2008 | isbn = 9789283224310 }}</ref>===
*T-cell and putative NK-cell neoplasms
**Precursor T-cell neoplasm: precursor T-acute lymphoblastic leukemia/LBL
**[[Peripheral T-cell lymphomas]] and [[NK-cell lymphomas]]
===Peripheral T Cell Lymphoma===
The WHO classification of T-cells [[NHL]] categorize them into Precursor T-cell neoplasm and Peripheral T-cell lymphomas/NK-cell neoplasms. The last one can be further subdivided into:
*T-cell [[prolymphocytic leukemia]]
*[[T-cell large granular lymphocytic leukemia]]
*[[Chronic lymphoproliferative disorder of NK cells]]
*[[Aggressive NK-cell leukemia]]
*EBV positive T-cell lymphoproliferative disorders of childhood
**[[Systemic EBV positive T-cell lymphoproliferative disease of childhood]]
**[[Hydroa vacciniforme-like lymphoma]]
*[[Adult T-cell lymphoma/leukemia]]
*[[Extranodal T-/NK-cell lymphoma, nasal type]]
*[[Enteropathy-associated T-cell lymphoma]]
*[[Hepatosplenic T-cell lymphoma]]
*[[Subcutaneous panniculitis-like T-cell lymphoma]]
*[[Mycosis fungoides]]
*[[Sézary syndrome]]
*[[Primary cutaneous CD30 positive T-cell lymphoproliferative disorders]]
**[[Primary cutaneous anaplastic large cell lymphoma]]
**[[Lymphomatoid papulosis]]
*Primary cutaneous peripheral T-cell lymphomas, rare subtypes
**[[Primary cutaneous gamma-delta T-cell lymphoma]]
**[[Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
**[[Primary cutaneous CD4 positive small/medium T-cell lymphoma]]
*[[Peripheral T-cell lymphoma, not otherwise characterized]]
*[[Angioimmunoblastic T-cell lymphoma]]
*[[Anaplastic large cell lymphoma, ALK positive]]
*[[Anaplastic large cell lymphoma, ALK negative]]
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 16:12, 29 October 2018

T-cell lymphoma Microchapters

Home

Patient Information

Overview

Classification

Lymphoblastic lymphoma
T-cell prolymphocytic leukemia
T-cell granular lymphocytic leukemia
Chronic lymphoproliferative disorder of NK cells
Aggressive NK-cell leukemia
Adult T-cell leukemia/lymphoma
Enteropathy-type intestinal T-cell lymphoma
Hepatosplenic T-cell lymphoma
Subcutaneous panniculitis-like T-cell lymphoma
Mycosis fungoides
Sézary syndrome
Angioimmunoblastic T-cell lymphoma
Anaplastic large cell lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

Tcell lymphoma may be classified according to The 2016 WHO update on mature T- and natural killer (NK) cell neoplasms.

OR

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

OR

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

OR

The staging of [malignancy name] is based on the [staging system].

OR

There is no established system for the staging of [malignancy name].

Classification

According to the the 2017 revision of the World Health Organization classification of lymphoid neoplasms classified there are four clinical variants of adult T cell leukemia-lymphoma (ATL).[1]

  • T cell prolymphocytic leukemia
  • T cell large granular lymphocytic leukemia
  • Aggressive NK cell leukemia
  • Systemic EBV+ T cell lymphoma of childhood*
  • Hydroa vacciniforme-like lymphoproliferative disorder*
  • Adult T cell leukemia/lymphoma
  • Extranodal NK/T cell lymphoma, nasal type
  • Enteropathy-associated T cell lymphoma
  • Monomorphic epitheliotropic intestinal T cell lymphoma*
  • Hepatosplenic T cell lymphoma
  • Subcutaneous panniculitis-like T cell lymphoma
  • Mycosis fungoides
  • Sézary syndrome
  • Primary cutaneous CD30+ T cell lymphoproliferative disorders
  • Lymphomatoid papulosis
  • Primary cutaneous anaplastic large cell lymphoma
  • Primary cutaneous γδ T cell lymphoma
  • Peripheral T cell lymphoma, NOS
  • Angioimmunoblastic T cell lymphoma
  • Anaplastic large cell lymphoma, ALK+
  • Anaplastic large cell lymphoma, ALK–

References

  1. Matutes, E. (2018). "The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms". International Journal of Laboratory Hematology. 40: 97–103. doi:10.1111/ijlh.12817. ISSN 1751-5521.